Physician profile
David E Cantral
NPI 1447233689
$744.22
in general payments reported to CMS, 2019-2025
20 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $28.36 · 2021: $67.89 · 2022: $113 · 2023: $73.36 · 2024: $201 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $93.11 | 2024 | Airsupra, Fasenra |
| Lilly USA, LLC | $83.27 | 2022-2025 | Mounjaro, Jardiance |
| Pfizer INC. | $83.20 | 2019-2025 | |
| Abbvie INC. | $75.34 | 2023-2024 | Dalvance |
| Amgen INC. | $51.12 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $44.96 | 2025 | Voquezna |
| Novo Nordisk INC | $42.00 | 2021-2025 | Ozempic, Rybelsus |
| Itamar Medical INC | $36.37 | 2022-2023 | Watchpatone |
| Takeda Pharmaceuticals U.S.A., INC. | $31.88 | 2022 | |
| Sanofi Pasteur INC. | $29.96 | 2020-2024 | |
| Vapotherm INC | $27.25 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.04 | 2019-2021 | |
| Verona Pharma, INC. | $18.94 | 2025 | Ohtuvayre |
| Insmed, INC. | $16.89 | 2019 | |
| Mallinckrodt Hospital Products INC. | $15.69 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $14.89 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $13.83 | 2021 | |
| Genzyme Corporation | $13.59 | 2019 | |
| Kci USA, INC. | $13.57 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cantral listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.